Australian Market Rises After Pfizer/BioNTech COVID-19 Vaccine Approval

The Australian stock market is modestly higher on Monday following the mixed cues from Wall Street Friday. Investor sentiment received a boost following news that the Pfizer/BioNTech COVID-19 vaccine has been approved for use in Australia, with the phased vaccine rollout set to commence in late February.